Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.

Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML, Brenner SK, Leonberg-Yoo A, Schenck EJ, Radbel J, Reiser J, Bansal A, Srivastava A, Zhou Y, Finkel D, Green A, Mallappallil M, Faugno AJ, Zhang J, Velez JCQ, Shaefi S, Parikh CR, Charytan DM, Athavale AM, Friedman AN, Redfern RE, Short SAP, Correa S, Pokharel KK, Admon AJ, Donnelly JP, Gershengorn HB, Douin DJ, Semler MW, Hernán MA, Leaf DE, STOP-COVID Investigators

Open source

DOI: 10.1001/jamainternmed.2020.6252
Published: 2021 Jan 1
Container: JAMA internal medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamainternmed.2020.6252,
  title = {Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.},
  author = {Gupta S and Wang W and Hayek SS and Chan L and Mathews KS and Melamed ML and Brenner SK and Leonberg-Yoo A and Schenck EJ and Radbel J and Reiser J and Bansal A and Srivastava A and Zhou Y and Finkel D and Green A and Mallappallil M and Faugno AJ and Zhang J and Velez JCQ and Shaefi S and Parikh CR and Charytan DM and Athavale AM and Friedman AN and Redfern RE and Short SAP and Correa S and Pokharel KK and Admon AJ and Donnelly JP and Gershengorn HB and Douin DJ and Semler MW and Hernán MA and Leaf DE and STOP-COVID Investigators},
  year = {2021},
  journal = {JAMA internal medicine},
  doi = {10.1001/jamainternmed.2020.6252},
  url = {https://doi.org/10.1001/jamainternmed.2020.6252}
}

RIS

TY  - JOUR
TI  - Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.
AU  - Gupta S
AU  - Wang W
AU  - Hayek SS
AU  - Chan L
AU  - Mathews KS
AU  - Melamed ML
AU  - Brenner SK
AU  - Leonberg-Yoo A
AU  - Schenck EJ
AU  - Radbel J
AU  - Reiser J
AU  - Bansal A
AU  - Srivastava A
AU  - Zhou Y
AU  - Finkel D
AU  - Green A
AU  - Mallappallil M
AU  - Faugno AJ
AU  - Zhang J
AU  - Velez JCQ
AU  - Shaefi S
AU  - Parikh CR
AU  - Charytan DM
AU  - Athavale AM
AU  - Friedman AN
AU  - Redfern RE
AU  - Short SAP
AU  - Correa S
AU  - Pokharel KK
AU  - Admon AJ
AU  - Donnelly JP
AU  - Gershengorn HB
AU  - Douin DJ
AU  - Semler MW
AU  - Hernán MA
AU  - Leaf DE
AU  - STOP-COVID Investigators
PY  - 2021
JO  - JAMA internal medicine
DO  - 10.1001/jamainternmed.2020.6252
UR  - https://doi.org/10.1001/jamainternmed.2020.6252
ER  -

APA

S, G., W, W., SS, H., L, C., KS, M., ML, M., SK, B., A, L., EJ, S., J, R., J, R., A, B., A, S., Y, Z., D, F., A, G., M, M., AJ, F., J, Z., JCQ, V., S, S., CR, P., DM, C., AM, A., AN, F., RE, R., SAP, S., S, C., KK, P., AJ, A., JP, D., HB, G., DJ, D., MW, S., MA, H., DE, L., & Investigators, S. (2021). Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19.. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2020.6252

Source records

pubmed · retrieved 2026-09-27T01:42:54.890Z